Index of reports
> Cases with Gait Disturbance (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zaroxolyn (Metolazone) where reactions include gait disturbance. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zaroxolyn side effects in 65 year old male
Reported by a consumer/non-health professional from United States on 2012-05-15
Patient: 65 year old male, weighing 99.8 kg (219.5 pounds)
Reactions: Dyspnoea, Body Height Abnormal, Heart Rate Decreased, Micturition Disorder, Dysuria, Gait Disturbance, Blood Pressure Abnormal, Asthenia, Myocardial Infarction
Drug(s) suspected as cause:
Revatio
Administration route: Oral
Indication: Lung Disorder
End date: 2012-04-11
Revatio
Administration route: Oral
Indication: Pulmonary Embolism
End date: 2012-04-11
Zaroxolyn
Administration route: Oral
Indication: Hypertension
End date: 2012-03-30
Other drugs received by patient: Allopurinol; Tracleer
Possible Zaroxolyn side effects in male
Reported by a consumer/non-health professional from United States on 2012-05-03
Patient: male, weighing 99.8 kg (219.5 pounds)
Reactions: Body Height Decreased, Dyspnoea, Cardiac Discomfort, Heart Rate Decreased, Micturition Disorder, Dysuria, Gait Disturbance, Asthenia
Drug(s) suspected as cause:
Zaroxolyn
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
End date: 2012-03-30
Revatio
Dosage: 20 mg, 3x/day
Administration route: Oral
Indication: Pulmonary Embolism
End date: 2012-04-11
Other drugs received by patient: Allopurinol; Tracleer
Possible Zaroxolyn side effects in male
Reported by a consumer/non-health professional from United States on 2012-04-20
Patient: male, weighing 99.8 kg (219.5 pounds)
Reactions: Body Height Decreased, Heart Rate Decreased, Dyspnoea, Cardiac Discomfort, Micturition Disorder, Dysuria, Pulmonary Oedema, Gait Disturbance, Asthenia, Cardiac Failure Congestive
Drug(s) suspected as cause:
Zaroxolyn
Dosage: 2.5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
End date: 2012-03-30
Revatio
Dosage: 20 mg, 3x/day
Administration route: Oral
Indication: Pulmonary Embolism
End date: 2012-04-11
Other drugs received by patient: Tracleer; Allopurinol
|